We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current EMMA market cap is 148.58M. The company's latest EPS is USD -0.0696 and P/E is -0.43.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 5.02M | 7.07M | 2.51M | 5.38M | 5.48M |
| Operating Income | -357k | 989k | -2.74M | 582k | 821k |
| Net Income | 67k | 1.21M | -4.35M | -2.18M | 1.83M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 22.75M | 23.17M | 20.61M | 18.39M | 29.6M |
| Operating Income | -4.93M | -2.35M | -8.86M | -8.5M | 1.83M |
| Net Income | -54.84M | 1.1M | -15.95M | -10.63M | -3.73M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 47.45M | 35.18M | 29.54M | 25.94M | 27.34M |
| Total Liabilities | 83.78M | 82.94M | 83.19M | 82.95M | 81.12M |
| Total Equity | -36.33M | -47.76M | -53.64M | -57.01M | -53.78M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 59.46M | 59.28M | 56.73M | 48.23M | 35.18M |
| Total Liabilities | 70.51M | 64.69M | 78.18M | 82.32M | 82.94M |
| Total Equity | -11.05M | -5.42M | -21.45M | -34.09M | -47.76M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -2.54M | -1.5M | 140k | -2.78M | -2.63M |
| Investing | -426k | -432k | -4k | 2.5M | 2.5M |
| Financing | 2.48M | 2.48M | -955k | -720k | -1.16M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.52M | -2.45M | -1.25M | -5.07M | -1.5M |
| Investing | -1.48M | 5.47M | -6.38M | -2.39M | -432k |
| Financing | 3.88M | -2.31M | 7.41M | 7.23M | 2.48M |
| Market Cap | 148.58M |
| Price to Earnings Ratio | -0.43 |
| Price to Sales Ratio | 0.05 |
| Price to Cash Ratio | 0.63 |
| Price to Book Ratio | -0.03 |
| Dividend Yield | - |
| Shares Outstanding | 53.64M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.12 (4.18%) |
| Company Name | Emmaus Life Sciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.emmausmedical.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
